top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Controversies in Medical Cannabis
Authors Anne Katrin Schlag, Saoirse E. O’Sullivan, Rayyan R. Zafar, David J.Nutt Published May 18, 2021 Knowledge about the therapeutic...
Dr Anne Schlag, Professor David Nutt and more
May 18, 20212 min read
Psychedelics and Nature Connection - In My Professional Opinion
There appears to be a growing disconnection between humans and their natural environments which has been linked to poor mental health and...
Drug Science
May 17, 20212 min read
Supervised Injection Facilities
Supervised Injection Facilities (SIFs) are known by many names including Safe Injection Facilities, Overdose Prevention Centres, and Drug...
Drug Science
May 13, 20213 min read
Project Twenty21 - May Update
In this update, we reveal the first paper to be published from Project Twenty21! We also share the latest data and patient experiences,...
Drug Science
May 12, 20213 min read
Medical Cannabis improves Quality of Life by over 50% - Preliminary Results from Project Twenty21
Authors C. Sakal, M. Lynskey, A. K. Schlag, D. J. Nutt Published May 11, 2021 We’re delighted to announce the first findings from Project...
Dr Anne Schlag, Professor David Nutt and more
May 11, 20215 min read
Drug Checking – The Evidence is Building!
Authors Fiona Measham & Gavin Turnbull Published May 10, 2021 What is a drug checking service? Drug checking has a rich history spanning...
Fiona Measham and Gavin Turnbull
May 10, 20218 min read
Ethical Implications of Psychedelics
The use of therapy assisted by psychedelics like psilocybin looks set to change the face of mental health care. But evidence from...
Drug Science
May 10, 20211 min read
Building a Career in Drug Science
After hearing feedback about challenges finding career opportunities from the Drug Science Student Society, this webinar provides insight...
Drug Science
May 6, 20213 min read
Illegal drugs in the UK: Is it time for considered legalisation to improve public health?
Authors: Phil Dalgarno, Steve O’Rawe, Richard Hammersley Published: April 28, 2021 This paper investigates options available to policy...
Phil Dalgarno, Steve O’Rawe and more
May 3, 20211 min read
Psychological Support in Psilocybin Therapy - In My Professional Opinion
What is the role of psychological support in psychedelic treatments? In this webinar, Dr Sara Tai will explain why it is essential that...
Drug Science
Apr 26, 20211 min read
Psilocybin for Anorexia Nervosa
In this webinar, Dr Meg Spriggs explains the potential of psilocybin to treat anorexia nervosa, and offers valuable insights from the...
Drug Science
Apr 22, 20211 min read
Psilocybin Therapy for Depression - Clinical Insights
After the release of the first comparison of psilocybin with an SSRI antidepressant, Michelle Baker Jones & Leonie Schneider explain what...
Drug Science
Apr 19, 20211 min read
Medical Cannabis Improves Patients’ Quality of Life More Than Any Other Treatment For Chronic Neuropathic Pain
Authors David J. Nutt, Lawrence D. Phillips, Michael P. Barnes, Brigitta Brander, Helen Valerie Curran, Alan Fayaz, David P. Finn, Tina...
Dr Anne Schlag, Professor David Nutt and more
Apr 14, 20214 min read
Project Twenty21 - April Update
In this update, we reveal the latest data and patient experiences with Project Twenty21, and reveal some exciting news from NICE. We also...
Drug Science
Apr 13, 20214 min read
How to Formulate Drug Policies and Provide Evidence-Based Regulation
Authors: Steve Rolles, David Nutt & Anne Schlag Published: April 7, 2021 How do we end the war on drugs? With mounting evidence...
Dr Anne Schlag, Professor David Nutt and more
Apr 7, 20213 min read
MDMA for Alcohol Use Disorder
In this webinar, Dr Ben Sessa explains how MDMA therapy could treat alcohol use disorder (alcoholism), based on results from his recent...
Drug Science
Apr 5, 20212 min read
Can a ‘double standard’ in paediatric medicine provide a framework to restructure repressive medical
By Rayyan Zafar an Honorary Research Assistant for Drug Science Can a ‘double standard’ in paediatric medicine provide a framework to...
Rayyan Zafar
Apr 1, 20216 min read
Charlie Hughes’ family drop their court case against NICE
We are greatly encouraged by the news that NICE updated their guidelines around medical cannabis for children with severe epilepsy. The...
Drug Science
Mar 31, 20213 min read
Women in Psychedelic Science - Part 3
The Contradictions of Ketamine: results from a new clinical trial treating alcohol use disorder – Prof Celia Morgan Celia Morgan is a...
Drug Science
Mar 29, 20212 min read
What would a regulated stimulant market look like?
Prohibition has failed to reduce drug-related deaths and unregulated stimulant drugs such as cocaine and MDMA pose a significant risk to...
Drug Science
Mar 25, 20211 min read
Nonclinical abuse liability testing of new CNS-active drugs: Role of sex as a critical factor for drug scheduling
Authors: David V Gauvin, Zachary J Zimmermann, Mary Jeanne Kallman Published: March 17, 2021 The trends in addiction medicine suggest...
David V Gauvin, Zachary J Zimmermann and more
Mar 18, 20212 min read
Investing in Psychedelic Companies
As clinical trials reveal more evidence for the therapeutic potential of psychedelic drugs such as psilocybin, DMT, and even entheogens...
Drug Science
Mar 18, 20211 min read
Project Twenty21 - March Update
In this update, we reveal the latest data and patient feedback from Project Twenty21, and answer some common questions from patients. We...
Drug Science
Mar 12, 20213 min read
Psilocybin Treatment for Depression - Clinical Insights
Psilocybin for depression is one of the most promising applications of psychedelic therapy. In particular, psilocybin therapy is being...
Drug Science
Mar 11, 20211 min read
bottom of page